Search the Newsreel

Proservice Building Services Marketplace Plc Revenue Breakdown – LSE:PRO

Neurosense Therapeutics is a buy, this analyst says

Roth Capital Partners analyst Boobalan Pachaiyappan has reaffirmed his "Buy" rating and $3.00 price target for Neurosense Therapeutics (NASDAQ:NRSN), citing reduced regulatory uncertainty for its ALS drug candidate, PrimeC, in Canada. Despite a recent stock dip, the company has aligned with Health Canada for …

Bessemer Group Inc. Sells 118,588 Shares of Millrose Properties, Inc. $MRP

Neurosense Therapeutics Ltd. Revenue Breakdown – FWB:H1Z

This article provides an overview of Neurosense Therapeutics Ltd. (H1Z) listed on the Frankfurt Stock Exchange. It highlights the availability of financial data, segments, and other fundamental statistics for the company on the TradingView platform. The content focuses on navigating the financial information for …

Neurosense Therapeutics Ltd (NRSN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution — TradingKey

This article provides a brief overview of Neurosense Therapeutics Ltd (NRSN), including its market capitalization and recent stock performance. It notes that relevant data regarding the company's revenue breakdown by business segments and regions have not yet been disclosed. The content suggests that detailed …

ESEA|Euroseas Ltd|Price:75.580|Chg%:-0.630

This article provides a comprehensive stock analysis of Euroseas Ltd (ESEA) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation within the Freight & Logistics Services industry. It notes high institutional ownership and recent "Buy" ratings from analysts. The report also …

Euroseas Ltd (ESEA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Euroseas Ltd (ESEA), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. While technical indicators show a mixed signal with some buys and sells, moving averages predominantly …

Euroseas Ltd (ESEA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Euroseas Ltd (ESEA), including major shareholders, institutional holdings, and shareholder activity. It breaks down ownership by entity type, lists key corporate and individual investors, and tracks changes in institutional holdings over several quarters.

Euroseas Ltd (ESEA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an in-depth timeline of Euroseas Ltd's (ESEA) dividend payouts, including ex-dividend, record, and payment dates, along with the gross amount paid per dividend. It shows that Euroseas has distributed over $42.05 million in dividends over the past five years. The data …

Neurosense Therapeutics Ltd (NRSN) Cash Flow

This article provides an analysis of Neurosense Therapeutics Ltd's (NRSN) cash flow, detailing its operating, investing, and financing activities. It highlights the company's operating cash flow of -7.67M in fiscal 2025 and a 24.31% year-over-year increase, along with capital expenditures of 8.00K and financing …

Kingsrose Mining Limited Confirms Expiry of 3 Million Options

NRSN|Neurosense Therapeutics Ltd|Price:0.602|Chg%:-0.048

This article provides an analysis of Neurosense Therapeutics Ltd (NRSN) including its stock score, financial performance, and risk assessment. TradingKey's comprehensive stock scoring system, which evaluates 34 indicators across six dimensions (financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment), …

Euroseas Shareholders Back Board and Auditors at 2026 Annual Meeting

Euroseas Ltd. held its 2026 Annual General Meeting of Shareholders on July 23, 2026, where shareholders re-elected key board members including President Aristides J. Pittas for three-year terms and approved Deloitte Certified Public Accountants, S.A. as independent auditors. This reinforces the company's leadership and …

Melrose Industries PLC Revenue Breakdown – LSE:MRO

TradingKey

This article provides a detailed financial overview of Neurosense Therapeutics Ltd (NRSN) with a focus on its income statement data. It presents quarterly and annual figures for key metrics such as operating expenses, R&D expenses, operating profit, net non-operating interest, income before and after …

Euroseas Ltd (ESEA) Q4 2025 Earnings Report - Results, Call & Slides

Euroseas Ltd (ESEA) reported its Q4 2025 earnings, with an actual EPS of $5.79, beating the consensus EPS of $5.57 by $0.22. However, the company missed revenue expectations, posting $57.39 million against an expected $57.79 million, though revenue still grew by 7.65% year-over-year. The …

Millrose Properties Inc Class A Revenue Breakdown – BMV:MRP

This article provides a financial overview and segments data for Millrose Properties Inc Class A (BMV:MRP) on the Mexican Stock Exchange. It highlights the availability of financial statements, dividends, earnings, and revenue breakdowns by source and country, all sourced from TradingView and FactSet. The …

Euroseas Ltd. Announces the Results of Its 2026 Annual General Meeting of Shareholders

Euroseas Ltd. announced the official results of its 2026 Annual General Meeting of Shareholders held on July 23, 2026. Shareholders re-elected Mr. Aristides J. Pittas, Mr. Anastasios Aslidis, and Mr. Aristides P. Pittas as Class A Directors and approved Deloitte Certified Public Accountants, S.A. …

Euroseas Ltd. (ESEA) files report on 2026 AGM results and F-3

Euroseas Ltd. (ESEA) has filed a Form 6-K report with the SEC in July 2026, announcing the results of its 2026 Annual General Meeting of Shareholders. This report, which includes a press release, is incorporated by reference into the company's existing Form F-3 registration …

Three Euroseas directors re-elected through 2029; Deloitte approved

Euroseas Ltd. announced the results of its 2026 Annual General Meeting of Shareholders, where three Class A Directors—Mr. Aristides J. Pittas, Mr. Anastasios Aslidis, and Mr. Aristides P. Pittas—were re-elected for three-year terms until the 2029 Annual Meeting. Additionally, Deloitte Certified Public Accountants, S.A. …

Should Value Investors Buy Euroseas (ESEA) Stock?

Euroseas (ESEA) is identified as a strong value stock by Zacks due to its Zacks Rank #1 (Strong Buy) and an "A" grade in Value. The article highlights appealing valuation metrics such as a low P/E ratio of 3.62, a P/B ratio of 1.09, …

NeuroSense Therapeutics (NRSN) Gains 3.08% as Stock Tests Key Resistance at $0.70 - Parabolic SAR

Is Euroseas (ESEA) Stock Outpacing Its Transportation Peers This Year?

For those looking to find strong Transportation stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Euroseas Ltd. (ESEA) been one of those stocks this year? By taking a look at the stock's year-to-date performance in …

NeuroSense Therapeutics (NASDAQ: NRSN) eyes Canada NDS for ALS drug

NeuroSense Therapeutics announced its intent to file a New Drug Submission (NDS) with Health Canada for PrimeC, its lead candidate for amyotrophic lateral sclerosis (ALS). This follows a positive Pre-NDS meeting where updated Phase 2b data, showing a 14.9-month median survival benefit and achievement …

NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS

NeuroSense Therapeutics announced its intention to file a New Drug Submission (NDS) with Health Canada for PrimeC, its treatment for amyotrophic lateral sclerosis (ALS). This decision follows a constructive pre-NDS meeting and is supported by additional data from the Phase 2b PARADIGM study, which …

NeuroSense Reports 14.9-Month Median Survival Benefit for PrimeC

Rosebank Industries lifts full-year outlook, shares jump

Rosebank Industries shares jump as forecasts profit ahead of consensus

Price-Driven Insight from (ESEA) for Rule-Based Strategy

This article provides a price-driven insight for Euroseas Ltd. (ESEA) using AI-generated signals for rule-based strategies. It highlights strong sentiment supporting an overweight bias, outlines specific institutional trading strategies for various risk profiles, and details multi-timeframe signal analysis with support and resistance levels.

Euroseas (NASDAQ:ESEA) Shares Pass Above Two Hundred Day Moving Average - Here's Why

Euroseas (NASDAQ:ESEA) shares recently traded above their 200-day moving average, reaching $71.61, indicating positive momentum. The company surpassed EPS expectations with $4.70, though revenue slightly missed forecasts. Analysts predict strong full-year earnings of $18.1 EPS, and the company increased its quarterly dividend to $0.80 …

AIM Market Roundup: Shaires, Proservice Building Marketplace, Zephyr Energy

ROSE Forecast — Price Target — Prediction for 2027

Previsión de CASH: precio objetivo 2027, TV

Melrose Industries: The Market Is Pricing In An Aerospace Growth Failure (OTCMKTS:MLSPF)

Is There Now An Opportunity In Melrose Industries PLC (LON:MRO)?

How I’m building a global stock portfolio for growth and passive income with IG Markets